The Microbial ID Breakthrough: How DNA Sequencing Services Prevent Catastrophic Cleanroom Shutdowns

A white paper by Dennis Champagne, Director, Laboratory Services, Microtest, Inc.

Modern cleanrooms, used for the manufacture of medical devices, pharmaceuticals, or combination products, face widespread, persistent threats of contamination by unknown organisms and often call for total shutdown of a cleanroom’s operation until that organism can be identified and eliminated. Such shutdowns can have catastrophic effects on the schedules and productivity of medical device and pharmaceutical manufacturers.

In his paper, Dennis Champagne Director, Laboratory Services, Microtest Labs, compares the shortcomings of traditional contamination identification methods to the benefits of DNA sequencing, which has proven highly accurate for microbial identification.

To download the paper, please fill out the form below. (Microtest respects your privacy. We will not give your email address to third parties or send you unwanted email.)